Vector VestAdvertisement
Home > Boards > US Listed > Medical - Drugs >

Tekmira Pharmaceuticals Corporation (TKMR)

TKMR RSS Feed
Add TKMR Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, nanopatent, KarinCA, willmakeitrain
Search This Board:
Last Post: 1/27/2015 2:33:49 PM - Followers: 113 - Board type: Free - Posts Today: 0

Tekmira Pharmaceuticals Corporation

 

(TSE:TKM, or US TKMR) 

 

 

http://www.tekmirapharm.com

 

 

 

 

 

Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201

 

As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.

 

Management:   http://www.tekmirapharm.com/Corporate/Management.asp

Pipeline:   http://www.tekmira.com/pipeline/pipeline-products.php 
 

Important Company Highlights: 

LNP Delivery Platform

http://www.tekmira.com/our-science/lnp-delivery-platform.php

Tekmira’s Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date. Administered intravenously, our LNP delivery technology allows RNAi drugs to be encapsulated in tiny particles made of lipids (fats or oils). These tiny particles – LNP – travel through the bloodstream to target tissues.

  

 

********************************************************************************************

 

Recent News:  

http://tmx.quotemedia.com/news.php?qm_symbol=TKM#page1
http://investor.tekmirapharm.com/releases.cfm
http://finance.yahoo.com/q?s=tkmr&ql=1 

http://www.marketwatch.com/investing/stock/tkmr/news

 ********************************************************************************************

 

Filings: 
http://www.tekmirapharm.com/Investors/Shareholder_Reports.asp

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001447028&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

Links of importance for those that trade Canadian stocks:

 Sedar:   http://www.sedar.com/homepage_en.htm

 TMX:.  http://www.tmx.com/

 TMXmoney:   http://www.tmxmoney.com/en/index.html

 CNW Group Newswire:   http://www.cnxmarketlink.com/en/index.cgi

Canadian Insider:    http://canadianinsider.com/coReport/allTransactions.php?ticker=tkm

Currency Converter:  http://www.bankofcanada.ca/en/rates/converter.html

 

Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

 
Share Structure:   See filings


Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 

CHART is for Canadian ticker.  Remember to adjust for exchange rate.

Currency Converter: 
http://www.bankofcanada.ca/en/rates/converter.html


 

 

 

 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TKMR
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for TKMR
TKMR News: Additional Proxy Soliciting Materials (definitive) (defa14a) 01/28/2015 06:01:49 AM
TKMR News: Current Report Filing (8-k) 01/28/2015 06:01:48 AM
TKMR News: Amended Current Report Filing (8-k/a) 01/26/2015 04:49:53 PM
TKMR News: Additional Proxy Soliciting Materials (definitive) (defa14a) 01/26/2015 04:47:49 PM
TKMR News: Proxy Statement - Merger or Acquistion (preliminary) (prem14a) 01/23/2015 05:20:26 PM
News News Alert: Additional Proxy Soliciting Materials (definitive) (defa14a) 01/28/2015 06:01:49 AM
PostSubject
#4559  Sticky Note Tekmira Announces Licensing and Collaboration Agreement willmakeitrain 11/17/14 08:37:57 AM
#4437  Sticky Note Tekmira to Host Analyst Day on November 21 nanopatent 11/05/14 08:16:42 PM
#1088  Sticky Note TKMR – Tekmira Pharmaceuticals Corp News, Filings and misc: KarinCA 08/10/14 01:52:25 AM
#4793   Tekmira Pharmaceutic (TKMR) mick 01/27/15 02:33:49 PM
#4792   Tekmira Pharmaceuticals Corporation (TKMR): Falcon Edge Capital Discloses nanopatent 01/26/15 09:08:54 PM
#4791   Tekmira Aims to Follow Path Blazed in HCV nanopatent 01/26/15 09:04:38 PM
#4790   https://propthink.com/consider-2-3x-upside-overlooked-hepatitis-b-stock muggel 01/26/15 05:44:15 PM
#4789   nice read Dr_Thorfin 01/26/15 04:38:23 AM
#4788   https://propthink.com/new-tekmira-emerges-hbv-frontrunner/ muggel 01/25/15 04:33:34 PM
#4787   Reasons for the Merger nanopatent 01/24/15 12:42:16 PM
#4786   For HBV - two heads are way better nanopatent 01/23/15 08:48:54 PM
#4785   can someone explain this filing to me and quick? HD3369 01/23/15 08:35:00 PM
#4784   Im pretty sure it'll hold. Just a pullbacl spades 01/23/15 07:40:41 PM
#4783   AVG volume (30D) = 1,343,066 Dr_Thorfin 01/23/15 02:28:12 PM
#4782   Don't forget volume to confirm breakout. John-Knee 01/23/15 02:01:12 PM
#4781   25 resistance broken, if it holds we have Dr_Thorfin 01/23/15 01:53:47 PM
#4780   TKMR 25.8 hitting it spades 01/23/15 12:08:12 PM
#4779   hope we breakout soon,hate the manipulation during first Dr_Thorfin 01/22/15 09:46:02 AM
#4778   It's hard to figure just how high this nanopatent 01/22/15 09:30:31 AM
#4777   saw that filling too Dr_Thorfin 01/22/15 06:08:09 AM
#4776   TKMR 24.2 wedge setting up. Target 32 spades 01/21/15 11:39:45 PM
#4775   It was revealed in a filing yesterday with nanopatent 01/21/15 09:54:27 PM
#4774   $94,500 sounds like a lot BUT once cured nanopatent 01/21/15 09:48:45 PM
#4773   $94,500 for one 12 week treatment? Dr_Thorfin 01/21/15 05:44:07 PM
#4772   When I see that for a typical 12-week nanopatent 01/21/15 03:43:39 PM
#4771   nice run leading to the closing bell Dr_Thorfin 01/21/15 03:05:13 PM
#4770   was in this for a quick trade,but the Dr_Thorfin 01/21/15 02:46:18 PM
#4769   I have no doubt at all that this nanopatent 01/21/15 02:38:20 PM
#4768   thinking conservative here,but if they would capture all Dr_Thorfin 01/21/15 02:34:38 PM
#4767   What if they could capture all of it! nanopatent 01/21/15 02:32:20 PM
#4766   350 million individuals worldwide infected with the hepatitis Dr_Thorfin 01/21/15 02:23:11 PM
#4765   HBV = GANGBUSTERS!! nanopatent 01/21/15 09:01:28 AM
#4764   Tekmira Initiates Phase I Clinical Trial of TKM-HBV TKM-HBV, John-Knee 01/21/15 08:38:35 AM
#4763   Tekmira Pharma (NASDAQ: TKMR) announced that the Company Dr_Thorfin 01/21/15 06:00:04 AM
#4762   MA support finaly catched up Dr_Thorfin 01/20/15 11:22:22 AM
#4761   golden cross Dr_Thorfin 01/20/15 09:39:19 AM
#4760   Now that Tekmira is about to merge OnCore KarinCA 01/19/15 07:09:36 PM
#4759   The New Billion Dollar Tekmira (TKMR) Includes Promising nanopatent 01/19/15 12:48:35 PM
#4758   I get the feeling that two drugs is nanopatent 01/18/15 03:38:19 PM
#4757   CONFERENCE CALL PARTICIPANTS Dr_Thorfin 01/18/15 03:17:16 PM
#4755   I'm smitten - don't know if I love nanopatent 01/16/15 06:51:45 PM
#4754   dr DR dr, I AM READING SOME OF mick 01/16/15 02:59:25 PM
#4753   stockcharts.com/def/servlet/SharpChartv05.ServletDriver?chart=TKMR,plamda mick 01/16/15 02:47:12 PM
#4752   once we break 25 its no resistance till 30 Dr_Thorfin 01/16/15 02:10:21 PM
#4751   true this merger we now have 3 new Dr_Thorfin 01/16/15 01:38:53 PM
#4750   I expect $50 - $60 real soon. nanopatent 01/16/15 01:31:34 PM
#4749   i think right now is a good moment Dr_Thorfin 01/16/15 01:28:19 PM
#4748   RBC Capital Boosts Tekmira Pharmaceuticals Price Target to nanopatent 01/16/15 01:26:21 PM
#4747   In re Google and Tekmira: nanopatent 01/16/15 01:02:07 PM
#4746   Google, as you may know, has a certain nanopatent 01/16/15 12:42:45 PM
#4745   I would like to see more volume. After John-Knee 01/16/15 12:05:20 PM
#4744   Will Tekmira surpass Google in stock price? nanopatent 01/16/15 10:20:52 AM
#4743   golden cross about to happen Dr_Thorfin 01/16/15 09:49:27 AM
PostSubject